Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 220-225

  Yagura, Chiaki ^a,b   Takamura, Noboru ^a   Kadota, Koichiro ^a   Nagazumi, Tatsuki ^b   Morishita, Yukiko ^c   Nakazato, Mio ^a   Maeda, Takahiro ^a   Kusano, Yosuke ^d   Abe, Yasuyo ^a   Aoyagi, Kiyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c KYUSHU UNIVERSITY OF NURSING AND SOCIAL WELFARE   (Japan)

^d Nagasaki Wesleyan University   (Japan)

Author keywords

Atherosclerosis; Cardio ankle vascular index; Carotid intima media thickness; Folate; Homocysteine; Young adults

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL CHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLIC ACID BLOOD LEVEL; HEMODYNAMICS; HUMAN; HYPERHOMOCYSTEINEMIA; INTIMA; JAPAN; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; JAPAN; REGRESSION ANALYSIS; RISK FACTORS; TUNICA INTIMA;

EID: 33847140643     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.047     Document Type: Article

References (31)

1. Oren A, Vos LE, Uiterwaal CS, Grobbee DE, Bots ML. Cardiovascular risk factors and increased carotid intimamedia thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med 2003;163:1787-92.
2. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc 2001;285:2481-5.
3. de Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002;54:599-618.
4. Voutilainen S, Morrow JD, Roberts LJ II, Alfthan G, Alho H, Nyyssonen K, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999;19:1263-6.
5. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C→ T polymorphism and risk of coronary heart disease: a meta-analysis. J Am Med Assoc 2002;288:2023-31.
6. 6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998;97:437-43.
7. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998;316:894-8.
8. Wilmink HW, Stroes ES, Erkelens WD, Gerritsen WB, Wever R, Banga JD, et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000;20:185-8.
9. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478-87.
10. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
11. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DS. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 1999;130:578-81.
12. Sass C, Zannad F, Herbeth B, Salah D, Chapet O, Siest G, et al. Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis 1998;140:89-95.
13. Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation 1999;100:838-42.
14. Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke 2001;32:830-5.
15. Adachi H, Hirai Y, Fujiura Y, Matsuoka H, Satoh A, Imaizumi T. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 2002;33:2177-81.
16. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001;32:454-60.
17. Zureik M, Bureau JM, Temmar M, Adamopoulos C, Courbon D, Bean K, et al. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension 2003;41:519-27.
18. Sutton-Tyrrell K, Wildman R, Newman A, Kuller LH. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch Intern Med 2003;163:2728-31.
19. Woodside JV, McMahon R, Gallagher AM, Cran GW, Boreham CA, Murray LJ, et al. Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults. Atherosclerosis 2004;177:337-44.
20. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, et al. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother 2004;58:S95-8.
21. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006;13:101-7.
22. Yambe T, Meng X, Hou X, Wang Q, Sekine K, Shiraishi Y, et al. Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantation. Biomed Pharmacother 2005;59:S177-9.
23. Garcia AJ, Apitz-Castro R. Plasma total homocysteine quantification: an improvement of the classical highperformance liquid chromatographic method with fluorescence detection of the thiol-SBD derivatives. J Chromatogr B 2002;779:359-63.
24. Hara T, Takamura N, Akashi S, Nakazato M, Maeda T, Wada M, et al. Evaluation of clinical markers of atherosclerosis in young and elderly Japanese adults. Clin Chem Lab Med 2006;44:824-9.
25. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
26. de Bree A, Verschuren WM, Blom HJ, de Graaf-Hess A, Trijbels FJ, Kromhout D. The homocysteine distribution: (mis)judging the burden. J Clin Epidemiol 2001;54:462-9.
27. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
28. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotidartery stenosis. N Engl J Med 1995;332:286-91.
29. Spence JD, Malinow MR, Barnett PA, Marian AJ, Freeman D, Hegele RA. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke 1999;30:969-73.
30. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Circulation 1999;99:2383-8.
31. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 2004;176:1-19.